Amedisys Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys (AMED) Reports In-Line Q1 EPS
May 3, 2016 5:33 PM EDTAmedisys (NASDAQ: AMED) reported Q1 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $348.8 million versus the consensus estimate of $337.07 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
... More


